Hypochlorite

Overview

Hypochlorite is an ion composed of chlorine and oxygen with the chemical formula ClO−. Being unstable in the pure form, hypochlorite is most commonly used for bleaching, disinfectation, and water treatment purposes in its salt form, sodium hypochlorite. Hypochlorite is often used as a chemical reagent for chlorination and oxidation reactions.

Indication

Indicated for over-the-counter use as a disinfectant agent in the sodium hypochlorite form.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Pulpotomy Materials in Primary Molars	2025/08/13	NCT07120321	Not Applicable	Completed	Sacide Duman
Chitosan Irrigation in Premolar Root Canal Therapy (Randomized Trial)	2025/07/02	NCT07048028	Not Applicable	Recruiting	ESRA DAĞCI
Moringa Oleifera vs Sodium Hypochlorite for Root Canal Irrigation in Nonvital Primary Molars	2025/05/14	NCT06971055	Not Applicable	Not yet recruiting	Cairo University
Comparison of Effectiveness of Disinfectants	2025/02/06	NCT06811779	Phase 1	Completed	Armed Forces Institute of Dentistry, Pakistan
Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques	2023/08/21	NCT06002646	Phase 4	Completed	University of Sulaimani
Role of Propolis Endodontic Irrigant on Post-Operative Pain	2023/08/03	NCT05974748	Phase 3	Completed	Dow University of Health Sciences
Effect of Moringa Oleifera Leaf Extract on Postoperative Pain and Bacterial Reduction in Mandibular Premolars	2022/04/27	NCT05348824	Phase 2	UNKNOWN	Cairo University
Comparison of Antimicrobial Action of Sodium Hypochlorite and Polyhexamethylene Biguanide as Root Canal Irrigants	2022/04/01	NCT05306431	Phase 2	Completed	Altamash Institute of Dental Medicine
Treatment of Young Permanent Teeth With Different Adjuvant Approaches	2022/03/22	NCT05291195	Not Applicable	Completed	University of Belgrade
Effect of Propolis Nanoparticles on Postoperative Pain and Bacterial Reduction in Mandibular Premolars	2021/12/07	NCT05146713	Phase 2	UNKNOWN	Cairo University

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
EXSEPT (0.114%)	alcavis hdc llc	02245790	Liquid - Topical	0.114 %	5/1/2002
R 77 DPS	dr reckeweg canada	02095645	Drops - Oral	2 D / ML	12/31/1994
DAKIN'S SOLUTION 0.5% MODIFIED	century pharmaceuticals inc.	00658529	Solution - Topical	5 G / L	12/31/1986
EXSEPT	alcavis hdc llc	02245530	Liquid - Topical	0.057 %	5/1/2002

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access